CKLF and stroke disorder: However, it is unknown whether CKLF1 can induce immunological tolerance or mitigate nerve damage following stroke, and the regulation of CKLF1 expression and its molecular mechanism associated with changes in microglial phenotypic changes have not yet been elucidated, which seriously hinders research on this chemokine as a new anti-stroke therapeutic target.